
doi: 10.1111/pai.12733
handle: 2158/1166176
Tuscany is the first region in Italy to have implemented a neonatal screening for congenital immunodeficiencies using both tandem mass spectrometry for early and late-onset adenosine deaminase and purine-nucleoside phosphorylase deficiency (1) and multiplex Real-Time PCR for TREC and KREC quantification on Dried Blood Spots (DBS) (2). The screening program with TREC and KREC started on December 2013 and, basing on the last data update of March 2017, it has screened a total of 18981 newborns in these first 3 years. We have had no cases of low or diminished TRECs but 5 cases of low/absent KRECs. This article is protected by copyright. All rights reserved.
B-Lymphocytes; Biomarkers; Dried Blood Spot Testing; Humans; Immunologic Deficiency Syndromes; Infant, Newborn; Male; Multiplex Polymerase Chain Reaction; Neonatal Screening; Real-Time Polymerase Chain Reaction
B-Lymphocytes; Biomarkers; Dried Blood Spot Testing; Humans; Immunologic Deficiency Syndromes; Infant, Newborn; Male; Multiplex Polymerase Chain Reaction; Neonatal Screening; Real-Time Polymerase Chain Reaction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 8 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
